EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
You may also be interested in...
Environmental Working Group’s annual “‘Guide to Sunscreens” finds 30% of non-mineral sunscreen products contain controversial ingredient oxybenzone, down from 40% last year and 60% three years ago.
The Cosmetic, Toiletry and Perfumery Association hopes to leverage data submitted for the UK evaluation to defend oxybenzone, homosalate, octocrylene and other ingredients in the EU, partnering with Cosmetics Europe.
The European Commission’s Scientific Committee for Consumer Safety has been unable to get the data it needs to properly assess the safety of nanomaterials in cosmetic products. The European Commission expects REACH to address the issue, and that is probably not a prospect that industry stakeholders relish.